Home

Lifeward Ltd. - Ordinary Shares (LFWD)

0.7286
-0.0219 (-2.92%)
NASDAQ · Last Trade: Jul 12th, 1:16 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Competitors to Lifeward Ltd. - Ordinary Shares (LFWD)

Abbott Laboratories ABT -1.18%

Abbott Laboratories' offerings in diagnostics, medical devices, and nutritional products put it in competition with Lifeward, particularly in the diagnostics and health monitoring technologies. Abbott’s strong reputation in the industry, coupled with its commitment to cutting-edge innovation, provides it considerable market leverage. Lifeward may pursue niche segments, but Abbott's comprehensive global presence and diversified product range enhance its competitive advantage.

Boston Scientific BSX -0.64%

Boston Scientific is a significant competitor to Lifeward, focusing on less invasive medical solutions in various therapy categories, including cardiology and urology. With strong innovation and a commitment to research and development, Boston Scientific has secured a foothold in many treatment areas. Their extensive clinical trials and partnerships enhance their product credibility, enabling them to attract healthcare providers looking for effective patient solutions that directly compete with Lifeward's products.

Medtronic MDT +0.58%

Medtronic competes directly with Lifeward in the medical technology sector, particularly concerning innovative therapeutic solutions. As a global leader in medical device development, Medtronic has an extensive product portfolio and robust R&D capabilities, giving it a competitive edge in terms of product development and market reach. Their established distribution channels and brand recognition allow them to effectively deliver advanced healthcare solutions, thereby competing strongly against Lifeward's offerings.

Smith & Nephew SNN -2.54%

Smith & Nephew competes with Lifeward primarily in the advanced wound management and surgical devices markets. While Lifeward may focus on specific healthcare innovations, Smith & Nephew benefits from an extensive history and a broader product range in surgical devices and orthopedic reconstruction. Their established reputation and global supply chain advantage enable them to launch products more efficiently and bring competitive pricing to the market, which positions them favorably against Lifeward.

Zimmer Biomet ZBH -1.43%

Zimmer Biomet competes with Lifeward in the orthopedic medical device sector. The company has a well-established presence in joint reconstruction and sports medicine, boasting a strong portfolio of innovative products aimed at improving patient mobility. Although Lifeward may introduce novel solutions, Zimmer Biomet's extensive market experience and strong R&D investments help it maintain a leadership position, making it a tough competitor in the orthopedic field.